Investigating brain processes related to rewards in adolescents
Official title: Neuromelanin MRI: A Tool for Non-invasive Investigation of Dopaminergic Abnormalities in Adolescent Substance Use
Run by Stony Brook University · NCT06369623 · Data updated 2026-11-12
This study is looking at how the brain's reward system works in teenagers to see if it can help us understand and prevent substance use problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years to 17 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Stony Brook University Academic / other |
| Locations | 1 site (Stony Brook, New York) |
| Status | Recruiting |
| Started | April 6, 2024 |
| Main results expected | November 30, 2028 |
| Study ends | November 30, 2028 |
| Registry record updated | May 15, 2025 |
| Trial ID | NCT06369623 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking males and females aged 14-17 who can provide assent and have parental consent.
✕Probably not a fit
Patients with recent substance use, severe medical conditions, or those on medications affecting cerebral function may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll 300 adolescents aged 14-17 to explore the relationship between substance use and dopamine function through neuromelanin-sensitive MRI and functional brain imaging. Participants will undergo three in-person assessments over 36 months, including a baseline evaluation, an 18-month follow-up, and a 36-month follow-up, alongside remote assessments of substance use every 90 days. The study aims to identify brain mechanisms that could inform future treatments for preventing substance use disorders in youth.
Why it matters
Potential benefit: If successful, this research could lead to targeted interventions that prevent the onset of substance use disorders in adolescents.
How similar studies have gone: While this approach is novel in its specific focus on adolescent substance use and dopamine function, similar studies have shown promise in understanding reward-related neural processes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males and females ages 14-17 years-old; * English-speaking for assent and interview completion; * Capacity to provide assent. * For parents, the inclusion criteria will be willing and capacity to provide parental permission/consent. Exclusion Criteria: * current (within 6 months) use of medication that may affect cerebral function * history of severe medical or neurological illness, including stroke or seizure; * history of head trauma with loss of consciousness; * presence of metal in the body; * pregnancy or breastfeeding; * recent drug or alcohol use determined by positive urine toxicology or breathalyzer (to validate self-report assessment of substance use history); * lifetime use of psychotropic or other medication that could likely influence dopamine function, namely stimulant medication or antipsychotic medication, except a subgroup of 25 youth with history of prescribed stimulant medication and a subgroup of 15 youth with history antipsychotic medication will be enrolled for comparison purposes.
Where it's running
-
Stony Brook Medicine
Stony Brook, New York, United States Recruiting
Study contacts
- Study coordinator: Greg Perlman, PhD
- Email: greg.perlman@stonybrookmedicine.edu
- Phone: 1-631-638-1922
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
GENESIS: Understanding mental health and lifestyle needs of Ecuadorian adolescents
This project will look at mental health and lifestyle habits in 14–19-year-olds in Quito to see if lifestyle factors relate to well‑being and risk for mental health problems.
-
EmoTIChealth: a serious game to strengthen emotional skills in teens with and without chronic conditions
This project will try a digital serious game for 12–16-year-olds to boost socioemotional skills and offer tailored support for teens with asthma, food allergy, type 1 diabetes, or allergic rhinitis.
-
Stress patterns and anhedonia during adolescence
We will see if combining brain scans, stress hormones, and heart-rate measures can identify patterns linked to developing anhedonia in 13–15-year-olds.
-
Understanding how anxiety affects substance use in adolescents
This study is trying to see how anxiety affects substance use in kids aged 12-14 by looking at their brain activity and stress responses.
-
Helping adolescents discover their talents to improve life satisfaction
This study is testing a new program that helps teenagers find and develop their talents using virtual reality to see if it can improve their mental health and overall happiness.
-
Understanding factors affecting children and adolescents in the child welfare system
This study looks at the mental and physical health of children and teens in the child welfare system to see how they change over two years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.